Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
atopic, belinostat, choice, feedback, gemcitabine, immunocompetent, pralatrexate, Secondary
Removed:
contact, desire, discontinue, distancing, domestic, emergence, encouraging, evolve, exacerbated, geographic, hospital, initiating, inspectional, leveraging, monitor, postponed, predicted, regimen, remote, restricted, restricting, resumed, serving, shipping, staffing, transitioning, transport, ultimate, virtual
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view